Revenue and Profitability - Revenue for Q1 2021 reached ¥274,592,338.77, an increase of 30.46% compared to ¥210,478,418.69 in the same period last year[8] - Net profit attributable to shareholders was ¥7,565,354.59, up 26.13% from ¥5,998,155.25 year-over-year[8] - Basic earnings per share increased by 24.41% to ¥0.0474 from ¥0.0381 in the previous year[8] - The company reported a net profit of CNY 5,405,371.34, which is an increase from CNY 3,003,157.65, representing a growth of about 80%[74] - The company's total comprehensive income amounted to CNY 9,422,130.23, an increase from CNY 7,736,388.40 in the previous period, representing a growth of approximately 22%[70] Cash Flow and Financial Position - The net cash flow from operating activities was negative at -¥65,679,600.58, a decline of 216.84% compared to -¥20,729,630.89 in the same period last year[8] - The company’s cash flow from operating activities saw a 72.99% increase, reaching 43,639,610.47, driven by an increase in bid-related cash deposits[22] - The total cash inflow from operating activities was CNY 625,560,621.21, compared to CNY 571,082,568.35 in the previous period, showing an increase of approximately 9.5%[82] - The cash flow from financing activities resulted in a net outflow of -20,437,413.89 CNY, compared to -3,524,431.92 CNY in the previous period, indicating increased financing costs[88] - The company reported a net cash flow from investment activities of 26,919,505.99 CNY[88] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,076,395,313.00, reflecting a 0.92% increase from ¥1,066,541,854.58 at the end of the previous year[8] - Total liabilities decreased slightly to CNY 473,406,718.41 from CNY 475,564,874.54, a reduction of about 0.5%[49] - The company’s total liabilities decreased significantly, with accounts payable to employees dropping by 40.78% to 9,506,918.33[22] - The total current assets amounted to CNY 1,014,440,563.25, a slight increase from CNY 1,003,929,435.09 at the end of 2020, representing a growth of approximately 1.5%[43] - The total non-current assets amounted to CNY 61,954,749.75, slightly down from CNY 62,612,419.49, indicating a decrease of approximately 1.0%[46] Expenses and Investments - Research and development expenses increased by 54.33% to 10,014,601.37 from 6,489,065.71 in the same period last year[22] - The company’s financial expenses surged by 349.44% to 647,613.57, primarily due to increased foreign exchange losses[22] - The cash outflow for purchasing fixed assets increased by 290.08% to 5,494,096.47, reflecting an increase in leased fixed asset acquisitions[24] - The company incurred 20,000,000.00 CNY in debt repayment during the financing activities, compared to 10,000,000.00 CNY in the previous period[88] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 8,130[13] - Net assets attributable to shareholders increased by 1.85% to ¥559,270,513.74 from ¥549,115,674.83 at the end of the previous year[8] - The total equity attributable to shareholders increased to CNY 559,270,513.74 from CNY 549,115,674.83, representing a growth of approximately 1.9%[52] Government Support and Other Income - The company received government subsidies amounting to ¥625,000.00 during the reporting period[8] - The company reported a significant increase in other income, which rose by 4861.28% to 729,136.46, primarily due to increased government subsidies[22] - The company reported a non-operating income of ¥1,153,908.75 after tax adjustments[8]
东方中科(002819) - 2021 Q1 - 季度财报